Filing search / Agios Pharmaceuticals, Inc. / "Reimbursement"

Search information

Agios Pharmaceuticals, Inc.

Companies

"Reimbursement"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

102 results

Newest first Best match first

10-K

2024 FY

AGIO Agios Pharmaceuticals, Inc.

Annual report

and the availability of reimbursement from government and other third-party payors. Our commercial opportunity could be reduced or eliminated if our … as to the coverage and reimbursement status of products approved by the FDA and other government authorities. Thus, even if a product candidate

13 Feb 25

9:26am

10-Q

2024 Q3

AGIO Agios Pharmaceuticals, Inc.

Quarterly report

for clinical and commercial use, obtaining and maintaining regulatory approvals and pricing and reimbursement for our products, market acceptance … reimbursement and generate commercial demand that results in expected sales of PYRUKYND®; PYRUKYND® may become subject to unfavorable pricing regulations

31 Oct 24

9:20am

10-Q

2024 Q2

AGIO Agios Pharmaceuticals, Inc.

Quarterly report

and reimbursement for our products, market acceptance, managing global growth and operating expenses, availability of additional capital, competition … to successfully obtain third party reimbursement and generate commercial demand that results in expected sales of PYRUKYND®; PYRUKYND® may become subject

1 Aug 24

9:49am

10-Q

2024 Q1

AGIO Agios Pharmaceuticals, Inc.

Quarterly report

and supply of products for clinical and commercial use, obtaining and maintaining regulatory approvals and pricing and reimbursement for our products, market … reimbursement and generate commercial demand that results in expected sales of PYRUKYND®; PYRUKYND® may become subject to unfavorable pricing regulations

2 May 24

9:20am

DEF 14A

AGIO Agios Pharmaceuticals, Inc.

Definitive proxy

reimbursement, mentorship programs, our DevelOPPortunities Program – which offers temporary, part time assignments that provide employees

26 Apr 24

4:02pm

10-K

vgkupu92e 3tt

Annual report

15 Feb 24

10:33am

10-Q

ldt3603mc21e7t

Quarterly report

2 Nov 23

9:20am

10-Q

qivrqc2a wn0au

Quarterly report

3 Aug 23

9:20am

Registration of securities for employees

Departure of Directors or Certain Officers

4 May 23

9:55am

4 May 23

9:55am

DEF 14A

uw8t0gwb63dw7zvhczr

Definitive proxy

26 Apr 23

4:03pm

8-K

wy32h0dn3 54q9r

19 Apr 23

Departure of Directors or Certain Officers

3 Nov 22

9:46am

3 Nov 22

9:46am

8-K

puzik eti7

15 Aug 22

Departure of Directors or Certain Officers

4 Aug 22

9:52am

10-Q

l9cmhby3zqog2o06p7j

Quarterly report

4 Aug 22

9:52am

10-Q

ndcsh

Quarterly report

5 May 22

9:46am

Filing search / Agios Pharmaceuticals, Inc. / "Reimbursement"

102 results

Top filers

Top filing types

Recent filing years